PROVIDES RELIABLE RESULTS

SITZMARKS test results can also show early detection of GI motility issues or indication of potentially serious or sometimes life-threatening GI conditions, such as a blockage.

 

This important step in your evaluation provides both you and your patient the opportunity to discuss and agree on the best treatment options.

FACTS

*Harris LA, Hansel S, DiBaise J, Crowell MD. Irritable bowel syndrome and chronic constipation: Emerging drugs, devices, and surgical treatments. Current Gastroenterology Report 2006; 8:282–90; **Review Team: Lindberg G, (Chairman), Hamid S (Pakistan), Malfertheiner P (Germany), Thomsen O (Denmark), Bustos Fernandez L (Argentina), Garisch J (South Africa), Thomson A (Canada), Goh K-L (Malaysia), Tandon R (India), Fedail S (Sudan), Wong B (China), Khan A (Pakistan), Krabshuis J (France), Le Mair A (The Netherlands). World Gastroenterology Organisation Global Guidelines. World Gastroenterology Organisation; November 2010; Crowell M, Harris L, Lunsford T, DiBaise J. Emerging drugs for chronic constipation. Expert Opinion on Emerging Drugs 2009; 1-2.

UP TO 20%

OF THE POPULATION CAN BE AFFECTED

BY CONSTIPATION*

ONLY A FEW

OF THESE INDIVIDUALS SEEK MEDICAL CARE**

2.5M OFFICE VISITS

A YEAR DUE TO CONSTIPATION RELATED SYMPTOMS***

Konsyl Script Black.png

SITZMARKS

c/o Konsyl Pharmaceuticals, Inc.
8050 Industrial Park Rd.
Easton, MD 21601

+1.410.822.5192 | 8:30 am - 5 pm ET

SITZMARKS and Konsyl Original Formula are registered trademarks of Konsyl Pharmaceuticals, Inc.

Rx only. For directions and indications for use, please refer to the Indications for Use. Interpretation and Consultation: a healthcare provider must analyze and interpret the test data and review the results. This website is intended to supplement the directions and explanations from the prescribing healthcare provider regarding use of the SITZMARKS. This website does not replace a healthcare provider’s care, advice, and specific instructions regarding SITZMARKS.

For more information, please call SITZMARKS c/o Konsyl Pharmaceuticals at +1.410.822.5192, 8 am - 5 pm EST. Prior to use, refer to the Indications For Use supplied with SITZMARKS for indications, contraindications, side effects, suggested procedure, warnings and precautions.